Saxenda weight loss injection is a once-daily injectable medication designed to assist individuals on their weight loss journey. Backed by extensive clinical studies (novoMEDLINK, 2022; Clinical Trials Arena, 2023; Mehta et al, 2017), Saxenda has proven its effectiveness in helping people shed more pounds than they would through dieting alone. This weight loss treatment is tailored for adults aged 18 and above and delivers optimal results when complemented by a low-fat, reduced-calorie diet and increased physical activity (Saxenda, 2021).

Saxenda contains Liraglutide as its active ingredient, mimicking the actions of a natural hormone called GLP-1 found in the body (Unger & Parkin, 2011). This hormone helps regulate a low blood sugar level after eating (Matsumoto et al, 2013). By replicating these effects, Saxenda assists the brain in recognizing fullness even with reduced food intake (Perone et al, 2023), ultimately reducing calorie consumption and facilitating weight loss.

Saxenda has undergone rigorous testing for weight loss promotion and demonstrated impressive results. In a 56-week trial involving 3,731 participants, Saxenda facilitated an average weight loss of 8% of their body weight (Palmer & Apovian, 2017). Moreover, 92% of participants experienced significant weight loss when Saxenda was combined with diet and exercise (Pi-Sunyer et al, 2015).